Bodycote plc (LON:BOY)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 1.17B +33.4% |
| Revenue (ttm) | 727.10M -4.0% |
| Net Income | 54.90M +174.5% |
| EPS | 0.31 +189.7% |
| Shares Out | 171.26M |
| PE Ratio | 21.97 |
| Forward PE | 13.99 |
| Dividend | 0.23 (3.38%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 10,593 |
| Average Volume | 307,746 |
| Open | 680.00 |
| Previous Close | 681.00 |
| Day's Range | 678.50 - 681.00 |
| 52-Week Range | 459.40 - 803.00 |
| Beta | 1.34 |
| RSI | 48.24 |
| Earnings Date | May 1, 2026 |
About Bodycote
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in Specialist Technologies and Precision Heat Treatment divisions. The company offers heat treatment services, including altering the microstructure of metals and alloys, which include steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and furnace/vacuum brazing; and hot... [Read more]
Financial Performance
In 2025, Bodycote's revenue was 727.10 million, a decrease of -3.96% compared to the previous year's 757.10 million. Earnings were 54.90 million, an increase of 174.50%.
Financial StatementsNews
Bodycote Earnings Call Transcript: H2 2025
Stable core revenues in 2025 with strong H2 momentum in Aerospace & Defense, while oil and gas and auto markets remained weak. Margin and EPS declined, but cash conversion and balance sheet stayed robust. 2026 outlook is for organic growth and margin expansion, led by aerospace and IGT.
Bodycote Earnings Call Transcript: H1 2025
Sequential revenue growth and strong execution offset tough end markets, with profit improvement expected in H2. Expanded Optimise program and targeted investments support medium-term growth, while aerospace and defence drive momentum.
Bodycote Earnings Call Transcript: H2 2024
Resilient 2024 performance with margin and cash flow improvements, despite tough markets. Specialist technologies led growth, while precision heat treatment remained resilient. Strategic optimization, sustainability progress, and disciplined capital allocation position the business for medium-term margin and growth targets.
Bodycote Transcript: Trading Update
Organic revenue growth remains modest but positive, with Specialist Technologies and energy segments outperforming, while industrial markets lag. Cost management and capital allocation are disciplined, with continued investment in high-growth areas and a major share buyback nearing completion.
Bodycote Earnings Call Transcript: H1 2024
First-half results showed margin and profit growth led by specialist technologies, with strong aerospace and energy segments offsetting weakness in automotive and industrial markets. A GBP 28.3 million SAP write-off and FX headwinds impacted results, but the outlook for margin expansion and organic growth remains positive.